National Cancer Institute Selects CambridgeSoft Corporation to Support Chemical Biology Consortium

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice Enterprise suite will allow members of the Consortium to manage and share vital scientific information.

MORE ON THIS TOPIC